About the role
Position Summary: Reporting into our CFO & Head of Strategy, the (Senior) Director, FP&A (depending on experience) will lead financial planning, forecasting, and reporting at Orca Bio, building upon our existing FP&A processes to scale into a commercial-ready function. This individual will serve as the functional leader for FP&A and is a highly visible, hands-on leader responsible for evolving our structure, processes, and financial rigor in a fast-growing, pre-commercial biotech environment. The role partners closely with Clinical Development, R&D, Manufacturing Operations, Medical Affairs, and Commercial leadership to drive budgeting, forecasting, and decision support across the organization.
This position will focus on core FP&A responsibilities (budgeting, forecasting, and operational finance), while partnering with leadership and adjacent functions on longer-term strategic and valuation-related initiatives.
Aplyr's read
Orca Bio pioneers advanced cell therapies for cancer, attracting professionals in biotechnology, quality control, and manufacturing operations.
What's promising
- •Orca Bio's proprietary platform offers innovative, targeted therapies for cancer treatment.
- •Recent expansion in roles indicates company growth and diversification.
- •Focus on advanced cell therapies positions Orca Bio at the forefront of biotechnology innovation.
What to watch
- •High specialization may limit opportunities for those outside biotechnology or life sciences.
- •The niche market focus can present financial volatility risks.
- •Demanding shift work, including nights and weekends, may affect work-life balance.
Why Orca Bio
- •Orca Bio's proprietary cell therapy platform sets it apart in the biotech industry.
- •The company's focus on both cancer and other diseases broadens its therapeutic impact.
- •Strong emphasis on quality control and manufacturing excellence ensures high product standards.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Orca Bio
Orca Bio is a biotechnology company focused on developing advanced cell therapies for cancer and other diseases, utilizing its proprietary platform to create targeted therapies.